MovDisordV3, PascalFrancis, Corpus, bibRecord, 001C27

Focal dystonia in musicians : Treatment strategies and long- term outcome in 144 patients

Identifieur interne : 001C27 ( PascalFrancis/Corpus ); précédent : 001C26; suivant : 001C28

Focal dystonia in musicians : Treatment strategies and long- term outcome in 144 patients

Auteurs : Hans-Christian Jabusch ; Dorothea Zschucke ; Alexander Schmidt ; Stephan Schuele ; Eckart Altenmüller

Source :

Movement disorders [ 0885-3185 ] ; 2005.

RBID : Pascal:06-0191532

Descripteurs français

Pascal (Inist)
- Système nerveux pathologie, Dystonie, Musicien, Traitement, Stratégie, Long terme, Pronostic, Homme, Bontoxilysin, Trihexyphénidyle, Ergonomie.

English descriptors

KwdEn :
- Bontoxilysin, Dystonia, Ergonomics, Human, Long term, Musician, Nervous system diseases, Prognosis, Strategy, Treatment, Trihexyphenidyl.

Abstract

We present the long-term outcome of 144 musicians with focal dystonia after treatment with botulinum toxin (n = 71), trihexyphenidyl (n = 69), pedagogical retraining (n = 24), ergonomic changes (n = 51), or nonspecific exercises on the instrument (n = 78). Outcome was assessed by patients' subjective rating of cumulative treatment response and response to individual therapies. Seventy-seven patients (54%) reported an alleviation of symptoms: 33% of the patients with trihexyphenidyl, 49% with botulinum toxin, 50% with pedagogical retraining, 56% with unmonitored technical exercises, and 63% with ergonomic changes.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

A01	`01`	`1`		`@0 0885-3185`
A03		`1`		`@0 Mov. disord.`
A05				`@2 20`
A06				`@2 12`
A08	`01`	`1`	`ENG`	`@1 Focal dystonia in musicians : Treatment strategies and long- term outcome in 144 patients`
A11	`01`	`1`		`@1 JABUSCH (Hans-Christian)`
A11	`02`	`1`		`@1 ZSCHUCKE (Dorothea)`
A11	`03`	`1`		`@1 SCHMIDT (Alexander)`
A11	`04`	`1`		`@1 SCHUELE (Stephan)`
A11	`05`	`1`		`@1 ALTENMÜLLER (Eckart)`
A14	`01`			`@1 Institute of Music Physiology and Musicians' Medicine, University of Music and Drama @2 Hannover @3 DEU @Z 1 aut. @Z 2 aut. @Z 3 aut. @Z 5 aut.`
A14	`02`			`@1 Department of Neurology and Medical Center for Performing Artists, Cleveland Clinic Foundation @2 Cleveland, Ohio @3 USA @Z 4 aut.`
A20				`@1 1623-1626`
A21				`@1 2005`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 20953 @5 354000153322170170`
A44				`@0 0000 @1 © 2006 INIST-CNRS. All rights reserved.`
A45				`@0 9 ref.`
A47	`01`	`1`		`@0 06-0191532`
A60				`@1 P @3 CC`
A61				`@0 A`
A64	`01`	`1`		`@0 Movement disorders`
A66	`01`			`@0 USA`
C01	`01`		`ENG`	@0 We present the long-term outcome of 144 musicians with focal dystonia after treatment with botulinum toxin (n = 71), trihexyphenidyl (n = 69), pedagogical retraining (n = 24), ergonomic changes (n = 51), or nonspecific exercises on the instrument (n = 78). Outcome was assessed by patients' subjective rating of cumulative treatment response and response to individual therapies. Seventy-seven patients (54%) reported an alleviation of symptoms: 33% of the patients with trihexyphenidyl, 49% with botulinum toxin, 50% with pedagogical retraining, 56% with unmonitored technical exercises, and 63% with ergonomic changes.
C02	`01`	`X`		`@0 002B17`
C02	`02`	`X`		`@0 002B17H`
C02	`03`	`X`		`@0 002B17F`
C03	`01`	`X`	`FRE`	`@0 Système nerveux pathologie @5 01`
C03	`01`	`X`	`ENG`	`@0 Nervous system diseases @5 01`
C03	`01`	`X`	`SPA`	`@0 Sistema nervioso patología @5 01`
C03	`02`	`X`	`FRE`	`@0 Dystonie @5 02`
C03	`02`	`X`	`ENG`	`@0 Dystonia @5 02`
C03	`02`	`X`	`SPA`	`@0 Distonía @5 02`
C03	`03`	`X`	`FRE`	`@0 Musicien @5 09`
C03	`03`	`X`	`ENG`	`@0 Musician @5 09`
C03	`03`	`X`	`SPA`	`@0 Músico @5 09`
C03	`04`	`X`	`FRE`	`@0 Traitement @5 10`
C03	`04`	`X`	`ENG`	`@0 Treatment @5 10`
C03	`04`	`X`	`SPA`	`@0 Tratamiento @5 10`
C03	`05`	`X`	`FRE`	`@0 Stratégie @5 11`
C03	`05`	`X`	`ENG`	`@0 Strategy @5 11`
C03	`05`	`X`	`SPA`	`@0 Estrategia @5 11`
C03	`06`	`X`	`FRE`	`@0 Long terme @5 12`
C03	`06`	`X`	`ENG`	`@0 Long term @5 12`
C03	`06`	`X`	`SPA`	`@0 Largo plazo @5 12`
C03	`07`	`X`	`FRE`	`@0 Pronostic @5 13`
C03	`07`	`X`	`ENG`	`@0 Prognosis @5 13`
C03	`07`	`X`	`SPA`	`@0 Pronóstico @5 13`
C03	`08`	`X`	`FRE`	`@0 Homme @5 14`
C03	`08`	`X`	`ENG`	`@0 Human @5 14`
C03	`08`	`X`	`SPA`	`@0 Hombre @5 14`
C03	`09`	`X`	`FRE`	`@0 Bontoxilysin @2 FE @2 FR @5 15`
C03	`09`	`X`	`ENG`	`@0 Bontoxilysin @2 FE @2 FR @5 15`
C03	`09`	`X`	`SPA`	`@0 Bontoxilysin @2 FE @2 FR @5 15`
C03	`10`	`X`	`FRE`	`@0 Trihexyphénidyle @2 NK @2 FR @5 16`
C03	`10`	`X`	`ENG`	`@0 Trihexyphenidyl @2 NK @2 FR @5 16`
C03	`10`	`X`	`SPA`	`@0 Trihexifenidilo @2 NK @2 FR @5 16`
C03	`11`	`X`	`FRE`	`@0 Ergonomie @5 17`
C03	`11`	`X`	`ENG`	`@0 Ergonomics @5 17`
C03	`11`	`X`	`SPA`	`@0 Ergonomía @5 17`
C07	`01`	`X`	`FRE`	`@0 Metalloendopeptidases @2 FE`
C07	`01`	`X`	`ENG`	`@0 Metalloendopeptidases @2 FE`
C07	`01`	`X`	`SPA`	`@0 Metalloendopeptidases @2 FE`
C07	`02`	`X`	`FRE`	`@0 Peptidases @2 FE`
C07	`02`	`X`	`ENG`	`@0 Peptidases @2 FE`
C07	`02`	`X`	`SPA`	`@0 Peptidases @2 FE`
C07	`03`	`X`	`FRE`	`@0 Hydrolases @2 FE`
C07	`03`	`X`	`ENG`	`@0 Hydrolases @2 FE`
C07	`03`	`X`	`SPA`	`@0 Hydrolases @2 FE`
C07	`04`	`X`	`FRE`	`@0 Enzyme @2 FE`
C07	`04`	`X`	`ENG`	`@0 Enzyme @2 FE`
C07	`04`	`X`	`SPA`	`@0 Enzima @2 FE`
C07	`05`	`X`	`FRE`	`@0 Extrapyramidal syndrome @5 37`
C07	`05`	`X`	`ENG`	`@0 Extrapyramidal syndrome @5 37`
C07	`05`	`X`	`SPA`	`@0 Extrapiramidal síndrome @5 37`
C07	`06`	`X`	`FRE`	`@0 Mouvement involontaire @5 38`
C07	`06`	`X`	`ENG`	`@0 Involuntary movement @5 38`
C07	`06`	`X`	`SPA`	`@0 Movimiento involuntario @5 38`
C07	`07`	`X`	`FRE`	`@0 Muscle strié pathologie @5 39`
C07	`07`	`X`	`ENG`	`@0 Striated muscle disease @5 39`
C07	`07`	`X`	`SPA`	`@0 Músculo estriado patología @5 39`
C07	`08`	`X`	`FRE`	`@0 Trouble neurologique @5 40`
C07	`08`	`X`	`ENG`	`@0 Neurological disorder @5 40`
C07	`08`	`X`	`SPA`	`@0 Trastorno neurológico @5 40`
C07	`09`	`X`	`FRE`	`@0 Encéphale pathologie @5 41`
C07	`09`	`X`	`ENG`	`@0 Cerebral disorder @5 41`
C07	`09`	`X`	`SPA`	`@0 Encéfalo patología @5 41`
C07	`10`	`X`	`FRE`	`@0 Système nerveux central pathologie @5 42`
C07	`10`	`X`	`ENG`	`@0 Central nervous system disease @5 42`
C07	`10`	`X`	`SPA`	`@0 Sistema nervosio central patología @5 42`
N21				`@1 114`
N44	`01`			`@1 OTO`
N82				`@1 OTO`

Format Inist (serveur)

NO :	PASCAL 06-0191532 INIST
ET :	Focal dystonia in musicians : Treatment strategies and long- term outcome in 144 patients
AU :	JABUSCH (Hans-Christian); ZSCHUCKE (Dorothea); SCHMIDT (Alexander); SCHUELE (Stephan); ALTENMÜLLER (Eckart)
AF :	Institute of Music Physiology and Musicians' Medicine, University of Music and Drama/Hannover/Allemagne (1 aut., 2 aut., 3 aut., 5 aut.); Department of Neurology and Medical Center for Performing Artists, Cleveland Clinic Foundation/Cleveland, Ohio/Etats-Unis (4 aut.)
DT :	Publication en série; Courte communication, note brève; Niveau analytique
SO :	Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2005; Vol. 20; No. 12; Pp. 1623-1626; Bibl. 9 ref.
LA :	Anglais
EA :	We present the long-term outcome of 144 musicians with focal dystonia after treatment with botulinum toxin (n = 71), trihexyphenidyl (n = 69), pedagogical retraining (n = 24), ergonomic changes (n = 51), or nonspecific exercises on the instrument (n = 78). Outcome was assessed by patients' subjective rating of cumulative treatment response and response to individual therapies. Seventy-seven patients (54%) reported an alleviation of symptoms: 33% of the patients with trihexyphenidyl, 49% with botulinum toxin, 50% with pedagogical retraining, 56% with unmonitored technical exercises, and 63% with ergonomic changes.
CC :	002B17; 002B17H; 002B17F
FD :	Système nerveux pathologie; Dystonie; Musicien; Traitement; Stratégie; Long terme; Pronostic; Homme; Bontoxilysin; Trihexyphénidyle; Ergonomie
FG :	Metalloendopeptidases; Peptidases; Hydrolases; Enzyme; Extrapyramidal syndrome; Mouvement involontaire; Muscle strié pathologie; Trouble neurologique; Encéphale pathologie; Système nerveux central pathologie
ED :	Nervous system diseases; Dystonia; Musician; Treatment; Strategy; Long term; Prognosis; Human; Bontoxilysin; Trihexyphenidyl; Ergonomics
EG :	Metalloendopeptidases; Peptidases; Hydrolases; Enzyme; Extrapyramidal syndrome; Involuntary movement; Striated muscle disease; Neurological disorder; Cerebral disorder; Central nervous system disease
SD :	Sistema nervioso patología; Distonía; Músico; Tratamiento; Estrategia; Largo plazo; Pronóstico; Hombre; Bontoxilysin; Trihexifenidilo; Ergonomía
LO :	INIST-20953.354000153322170170
ID :	06-0191532

Links to Exploration step

Pascal:06-0191532

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Focal dystonia in musicians : Treatment strategies and long- term outcome in 144 patients</title>
<author><name sortKey="Jabusch, Hans Christian" sort="Jabusch, Hans Christian" uniqKey="Jabusch H" first="Hans-Christian" last="Jabusch">Hans-Christian Jabusch</name>
<affiliation><inist:fA14 i1="01"><s1>Institute of Music Physiology and Musicians' Medicine, University of Music and Drama</s1>
<s2>Hannover</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Zschucke, Dorothea" sort="Zschucke, Dorothea" uniqKey="Zschucke D" first="Dorothea" last="Zschucke">Dorothea Zschucke</name>
<affiliation><inist:fA14 i1="01"><s1>Institute of Music Physiology and Musicians' Medicine, University of Music and Drama</s1>
<s2>Hannover</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Schmidt, Alexander" sort="Schmidt, Alexander" uniqKey="Schmidt A" first="Alexander" last="Schmidt">Alexander Schmidt</name>
<affiliation><inist:fA14 i1="01"><s1>Institute of Music Physiology and Musicians' Medicine, University of Music and Drama</s1>
<s2>Hannover</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Schuele, Stephan" sort="Schuele, Stephan" uniqKey="Schuele S" first="Stephan" last="Schuele">Stephan Schuele</name>
<affiliation><inist:fA14 i1="02"><s1>Department of Neurology and Medical Center for Performing Artists, Cleveland Clinic Foundation</s1>
<s2>Cleveland, Ohio</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Altenmuller, Eckart" sort="Altenmuller, Eckart" uniqKey="Altenmuller E" first="Eckart" last="Altenmüller">Eckart Altenmüller</name>
<affiliation><inist:fA14 i1="01"><s1>Institute of Music Physiology and Musicians' Medicine, University of Music and Drama</s1>
<s2>Hannover</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">06-0191532</idno>
<date when="2005">2005</date>
<idno type="stanalyst">PASCAL 06-0191532 INIST</idno>
<idno type="RBID">Pascal:06-0191532</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001C27</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Focal dystonia in musicians : Treatment strategies and long- term outcome in 144 patients</title>
<author><name sortKey="Jabusch, Hans Christian" sort="Jabusch, Hans Christian" uniqKey="Jabusch H" first="Hans-Christian" last="Jabusch">Hans-Christian Jabusch</name>
<affiliation><inist:fA14 i1="01"><s1>Institute of Music Physiology and Musicians' Medicine, University of Music and Drama</s1>
<s2>Hannover</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Zschucke, Dorothea" sort="Zschucke, Dorothea" uniqKey="Zschucke D" first="Dorothea" last="Zschucke">Dorothea Zschucke</name>
<affiliation><inist:fA14 i1="01"><s1>Institute of Music Physiology and Musicians' Medicine, University of Music and Drama</s1>
<s2>Hannover</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Schmidt, Alexander" sort="Schmidt, Alexander" uniqKey="Schmidt A" first="Alexander" last="Schmidt">Alexander Schmidt</name>
<affiliation><inist:fA14 i1="01"><s1>Institute of Music Physiology and Musicians' Medicine, University of Music and Drama</s1>
<s2>Hannover</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Schuele, Stephan" sort="Schuele, Stephan" uniqKey="Schuele S" first="Stephan" last="Schuele">Stephan Schuele</name>
<affiliation><inist:fA14 i1="02"><s1>Department of Neurology and Medical Center for Performing Artists, Cleveland Clinic Foundation</s1>
<s2>Cleveland, Ohio</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Altenmuller, Eckart" sort="Altenmuller, Eckart" uniqKey="Altenmuller E" first="Eckart" last="Altenmüller">Eckart Altenmüller</name>
<affiliation><inist:fA14 i1="01"><s1>Institute of Music Physiology and Musicians' Medicine, University of Music and Drama</s1>
<s2>Hannover</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2005">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Bontoxilysin</term>
<term>Dystonia</term>
<term>Ergonomics</term>
<term>Human</term>
<term>Long term</term>
<term>Musician</term>
<term>Nervous system diseases</term>
<term>Prognosis</term>
<term>Strategy</term>
<term>Treatment</term>
<term>Trihexyphenidyl</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Système nerveux pathologie</term>
<term>Dystonie</term>
<term>Musicien</term>
<term>Traitement</term>
<term>Stratégie</term>
<term>Long terme</term>
<term>Pronostic</term>
<term>Homme</term>
<term>Bontoxilysin</term>
<term>Trihexyphénidyle</term>
<term>Ergonomie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We present the long-term outcome of 144 musicians with focal dystonia after treatment with botulinum toxin (n = 71), trihexyphenidyl (n = 69), pedagogical retraining (n = 24), ergonomic changes (n = 51), or nonspecific exercises on the instrument (n = 78). Outcome was assessed by patients' subjective rating of cumulative treatment response and response to individual therapies. Seventy-seven patients (54%) reported an alleviation of symptoms: 33% of the patients with trihexyphenidyl, 49% with botulinum toxin, 50% with pedagogical retraining, 56% with unmonitored technical exercises, and 63% with ergonomic changes.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01>
<fA03 i2="1"><s0>Mov. disord.</s0>
</fA03>
<fA05><s2>20</s2>
</fA05>
<fA06><s2>12</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Focal dystonia in musicians : Treatment strategies and long- term outcome in 144 patients</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>JABUSCH (Hans-Christian)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>ZSCHUCKE (Dorothea)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>SCHMIDT (Alexander)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>SCHUELE (Stephan)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>ALTENMÜLLER (Eckart)</s1>
</fA11>
<fA14 i1="01"><s1>Institute of Music Physiology and Musicians' Medicine, University of Music and Drama</s1>
<s2>Hannover</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Department of Neurology and Medical Center for Performing Artists, Cleveland Clinic Foundation</s1>
<s2>Cleveland, Ohio</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</fA14>
<fA20><s1>1623-1626</s1>
</fA20>
<fA21><s1>2005</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000153322170170</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2006 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>9 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>06-0191532</s0>
</fA47>
<fA60><s1>P</s1>
<s3>CC</s3>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Movement disorders</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>We present the long-term outcome of 144 musicians with focal dystonia after treatment with botulinum toxin (n = 71), trihexyphenidyl (n = 69), pedagogical retraining (n = 24), ergonomic changes (n = 51), or nonspecific exercises on the instrument (n = 78). Outcome was assessed by patients' subjective rating of cumulative treatment response and response to individual therapies. Seventy-seven patients (54%) reported an alleviation of symptoms: 33% of the patients with trihexyphenidyl, 49% with botulinum toxin, 50% with pedagogical retraining, 56% with unmonitored technical exercises, and 63% with ergonomic changes.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B17</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B17H</s0>
</fC02>
<fC02 i1="03" i2="X"><s0>002B17F</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Dystonie</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Dystonia</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Distonía</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Musicien</s0>
<s5>09</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Musician</s0>
<s5>09</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Músico</s0>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Traitement</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Treatment</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Tratamiento</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Stratégie</s0>
<s5>11</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Strategy</s0>
<s5>11</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Estrategia</s0>
<s5>11</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Long terme</s0>
<s5>12</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Long term</s0>
<s5>12</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Largo plazo</s0>
<s5>12</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Pronostic</s0>
<s5>13</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Prognosis</s0>
<s5>13</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Pronóstico</s0>
<s5>13</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Homme</s0>
<s5>14</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Human</s0>
<s5>14</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Hombre</s0>
<s5>14</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Bontoxilysin</s0>
<s2>FE</s2>
<s2>FR</s2>
<s5>15</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Bontoxilysin</s0>
<s2>FE</s2>
<s2>FR</s2>
<s5>15</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Bontoxilysin</s0>
<s2>FE</s2>
<s2>FR</s2>
<s5>15</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Trihexyphénidyle</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>16</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Trihexyphenidyl</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>16</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Trihexifenidilo</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>16</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE"><s0>Ergonomie</s0>
<s5>17</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG"><s0>Ergonomics</s0>
<s5>17</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA"><s0>Ergonomía</s0>
<s5>17</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Metalloendopeptidases</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Metalloendopeptidases</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Metalloendopeptidases</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Peptidases</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Peptidases</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Peptidases</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Hydrolases</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Hydrolases</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Hydrolases</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Enzyme</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Enzyme</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Enzima</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Extrapyramidal syndrome</s0>
<s5>37</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>37</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>37</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Mouvement involontaire</s0>
<s5>38</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Involuntary movement</s0>
<s5>38</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Movimiento involuntario</s0>
<s5>38</s5>
</fC07>
<fC07 i1="07" i2="X" l="FRE"><s0>Muscle strié pathologie</s0>
<s5>39</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG"><s0>Striated muscle disease</s0>
<s5>39</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA"><s0>Músculo estriado patología</s0>
<s5>39</s5>
</fC07>
<fC07 i1="08" i2="X" l="FRE"><s0>Trouble neurologique</s0>
<s5>40</s5>
</fC07>
<fC07 i1="08" i2="X" l="ENG"><s0>Neurological disorder</s0>
<s5>40</s5>
</fC07>
<fC07 i1="08" i2="X" l="SPA"><s0>Trastorno neurológico</s0>
<s5>40</s5>
</fC07>
<fC07 i1="09" i2="X" l="FRE"><s0>Encéphale pathologie</s0>
<s5>41</s5>
</fC07>
<fC07 i1="09" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>41</s5>
</fC07>
<fC07 i1="09" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>41</s5>
</fC07>
<fC07 i1="10" i2="X" l="FRE"><s0>Système nerveux central pathologie</s0>
<s5>42</s5>
</fC07>
<fC07 i1="10" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>42</s5>
</fC07>
<fC07 i1="10" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>42</s5>
</fC07>
<fN21><s1>114</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
<server><NO>PASCAL 06-0191532 INIST</NO>
<ET>Focal dystonia in musicians : Treatment strategies and long- term outcome in 144 patients</ET>
<AU>JABUSCH (Hans-Christian); ZSCHUCKE (Dorothea); SCHMIDT (Alexander); SCHUELE (Stephan); ALTENMÜLLER (Eckart)</AU>
<AF>Institute of Music Physiology and Musicians' Medicine, University of Music and Drama/Hannover/Allemagne (1 aut., 2 aut., 3 aut., 5 aut.); Department of Neurology and Medical Center for Performing Artists, Cleveland Clinic Foundation/Cleveland, Ohio/Etats-Unis (4 aut.)</AF>
<DT>Publication en série; Courte communication, note brève; Niveau analytique</DT>
<SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2005; Vol. 20; No. 12; Pp. 1623-1626; Bibl. 9 ref.</SO>
<LA>Anglais</LA>
<EA>We present the long-term outcome of 144 musicians with focal dystonia after treatment with botulinum toxin (n = 71), trihexyphenidyl (n = 69), pedagogical retraining (n = 24), ergonomic changes (n = 51), or nonspecific exercises on the instrument (n = 78). Outcome was assessed by patients' subjective rating of cumulative treatment response and response to individual therapies. Seventy-seven patients (54%) reported an alleviation of symptoms: 33% of the patients with trihexyphenidyl, 49% with botulinum toxin, 50% with pedagogical retraining, 56% with unmonitored technical exercises, and 63% with ergonomic changes.</EA>
<CC>002B17; 002B17H; 002B17F</CC>
<FD>Système nerveux pathologie; Dystonie; Musicien; Traitement; Stratégie; Long terme; Pronostic; Homme; Bontoxilysin; Trihexyphénidyle; Ergonomie</FD>
<FG>Metalloendopeptidases; Peptidases; Hydrolases; Enzyme; Extrapyramidal syndrome; Mouvement involontaire; Muscle strié pathologie; Trouble neurologique; Encéphale pathologie; Système nerveux central pathologie</FG>
<ED>Nervous system diseases; Dystonia; Musician; Treatment; Strategy; Long term; Prognosis; Human; Bontoxilysin; Trihexyphenidyl; Ergonomics</ED>
<EG>Metalloendopeptidases; Peptidases; Hydrolases; Enzyme; Extrapyramidal syndrome; Involuntary movement; Striated muscle disease; Neurological disorder; Cerebral disorder; Central nervous system disease</EG>
<SD>Sistema nervioso patología; Distonía; Músico; Tratamiento; Estrategia; Largo plazo; Pronóstico; Hombre; Bontoxilysin; Trihexifenidilo; Ergonomía</SD>
<LO>INIST-20953.354000153322170170</LO>
<ID>06-0191532</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001C27 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 001C27 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:06-0191532
   |texte=   Focal dystonia in musicians : Treatment strategies and long- term outcome in 144 patients
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

Focal dystonia in musicians : Treatment strategies and long- term outcome in 144 patients

Focal dystonia in musicians : Treatment strategies and long- term outcome in 144 patients

Source :

Descripteurs français

English descriptors

Abstract

Notice en format standard (ISO 2709)

Format Inist (serveur)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri